Bausch & Lomb UK Ltd informed the MHRA in July 2019 of a risk of Emerade failing to deliver adrenaline due to blockage of the needle in approximately 1/400 devices. Click here for more details. Although the risk is low for any one patient, if healthcare professionals or patients have concerns, then changing to an EpiPen or JEXT might be considered for peace of mind.

WordPress Video Lightbox Plugin